Retrospective prognosis study of death at home or hospice versus at hospital end-of-life for advanced Non-Small Cell Lung Cancer
Not Applicable
- Conditions
- Advanced non-small cell lung cancer
- Registration Number
- JPRN-UMIN000022426
- Lead Sponsor
- ational Hospital Organization Nishisaitama-Chuo National Hospital Department of Pulmonary Medicine
- Brief Summary
Among the 313 patients recruited, 214 were analyzed in this study: 90, 49, and 75 received hospital-based, home-based, and hospice-based palliative care, respectively. The patients who died at a hospice exhibited significantly longer survival than those that died at hospital (estimated median survival time, 420 days [95% confidence interval, 325-612 days] vs. 252 days [95% CI, 201-316 days]; P<0.0001). The characteristics of patients did not differ significantly according to place of death.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 313
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Survival time from last chemotherapy